Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin H Busse

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacological enhancement of protease inhibitors with ritonavir: an updateKristin H Busse, Scott R Penzak
The Journal of the Oklahoma State Medical Association|November 21, 2007
Part XIII. Systemic antifungal therapyKristin H Busse, Chris A Gentry, Michael S Bronze, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individualsKristin H Busse, Elizabeth Formentini, Raul M Alfaro, et al.
Journal of Clinical Pharmacology|April 19, 2008
Limitations of using a single postdose midazolam concentration to predict CYP3A-mediated drug interactionsScott R Penzak, Kristin H Busse, Sarah M Robertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2009
Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavirKristin H Busse, Colleen Hadigan, Cheryl Chairez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2008
Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavirRoshan Ramanathan, Alice K Pau, Kristin H Busse, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Review of Clinical Pharmacology|January 14, 2014
Pharmacological enhancement of protease inhibitors with ritonavir: an updateKristin H Busse, Scott R Penzak
The Journal of the Oklahoma State Medical Association|November 21, 2007
Part XIII. Systemic antifungal therapyKristin H Busse, Chris A Gentry, Michael S Bronze, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individualsKristin H Busse, Elizabeth Formentini, Raul M Alfaro, et al.
Journal of Clinical Pharmacology|April 19, 2008
Limitations of using a single postdose midazolam concentration to predict CYP3A-mediated drug interactionsScott R Penzak, Kristin H Busse, Sarah M Robertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2009
Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavirKristin H Busse, Colleen Hadigan, Cheryl Chairez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2008
Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavirRoshan Ramanathan, Alice K Pau, Kristin H Busse, et al.
Pageof 1